Pharmaceuticals
Parallel import blockade for a specialty pharma brand
Unauthorized cross-border diversion into regulated markets — coordinated legal and platform action to restore MAP compliance.
6
Markets restored
60 days
Time to compliance
−100%
Regulatory complaints
Challenge
Parallel importers were sourcing the brand's products from low-regulation markets and redistributing into high-margin specialty pharmacy channels, triggering regulatory scrutiny and MAP投诉.
Approach
Tracer shipment analysis, UPP enforcement across six jurisdictions, and pharmacy-level notifications with documented harm evidence. Coordinated with legal for customs alerts in three countries.
Outcome
Regulatory complaints related to diverted product dropped to zero within 60 days. The enforcement database now flags repeat diversion sources automatically.
Model something similar
We can stress-test your enforcement lanes and propose a phased operating plan with realistic SLAs.
Talk to the team →